AstraZeneca buys French biotech firm Amolyt for $1 bn

March 14, 2024 | 17:20

(0) user say

Anglo-Swedish pharmaceuticals giant AstraZeneca on Thursday agreed to buy French biotech specialist Amolyt Pharma for about $1 billion, expanding further into the field of rare drugs.

"AstraZeneca ... has entered into a definitive agreement to acquire Amolyt Pharma, a clinical-stage biotechnology company focused on developing novel treatments for rare endocrine diseases," it said in a statement.

AstraZeneca buys French biotech firm Amolyt for $1 bn, Source: amolytpharma.com

The London-listed group added that the transaction would bolster its rare diseases division Alexion.

It will pay $800 million upfront for the Lyon-based company, plus an additional payment of $250 million payable after a specified regulatory milestone is reached.

"We enthusiastically welcome the proposed acquisition of Amolyt by AstraZeneca, an organisation that shares our dedication to delivering life-changing treatments to people living with rare diseases," added Amolyt Pharma chief executive Thierry Abribat.

"This agreement offers the opportunity to meaningfully advance our pipeline therapies."

AstraZeneca's share price was up 0.1 percent in early morning London trading following the news.

"The deal adds weight behind Astra's rare disease division," said Sophie Lund-Yates, lead equity analyst at stockbroker Hargreaves Lansdown, noting that Amoly is developing a treatment for an endocrine disorder which is in the final phase of clinical trials.

"This addition to the pipeline looks to be potentially lucrative."

The transaction is expected to close by the end of the third quarter.

AstraZeneca Vietnam chairman awarded Friendship Medal

Nitin Kapoor, chairman and general director of AstraZeneca Vietnam, has been bestowed with the Friendship Medal by State President in recognition of his extraordinary leadership during the pandemic and in his relentless pursuit of ongoing healthcare improvements.

AstraZeneca, VYPA sign MOU to enhance healthcare in Vietnam

AstraZeneca Vietnam and the Vietnam Young Physicians Association (VYPA) on January 28 signed a MoU to elevate cooperation between the two organisations to new heights.

AstraZeneca Vietnam dedicated to health

AstraZeneca Vietnam has started the year by building on last year’s success with programmes that cater to improving livelihoods and enhancing healthcare.

By AFP

What the stars mean:

★ Poor ★ ★ Promising ★★★ Good ★★★★ Very good ★★★★★ Exceptional